Argan Slides as Investors Appear to Take Profits After Big Run

Argan, Inc. (AGX) is down 4.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is profit-taking after a sharp rally, rather than a clearly negative company-specific announcement. Argan’s most recent quarterly results were strong, but the stock had already run up significantly, and recent commentary around valuation suggests some investors may be locking in gains. This could also be because there has been no fresh contract win or earnings update since early June to support the stock’s elevated level.

Details:

Argan’s latest reported quarter showed record revenue of about $291.0 million, diluted EPS of $3.24, and backlog of roughly $2.8 billion, pointing to continued underlying business strength.

The company said demand remains robust as electrification, domestic manufacturing buildouts, and data center growth increase the need for power infrastructure projects.

Argan also disclosed nearly $973.6 million in cash, cash equivalents, and investments at April 30, 2026, with no debt, which suggests the selloff does not appear tied to balance-sheet stress.

Recent market commentary has highlighted Argan’s rich valuation after its powerful advance, which fits a pullback driven by sentiment and position trimming more than by deteriorating fundamentals.

Sources:

SEC, Stock Analysis, TipRanks

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AGX Insider Trading Activity

$AGX insiders have traded $AGX stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.

Here’s a breakdown of recent trading of $AGX stock by insiders over the last 6 months:

WILLIAM F JR GRIFFIN has made 0 purchases and 2 sales selling 50,000 shares for an estimated $36,984,100.
DAVID HIBBERT WATSON (PRESIDENT AND CEO) has made 0 purchases and 3 sales selling 31,183 shares for an estimated $19,464,203.
WILLIAM F. LEIMKUHLER has made 0 purchases and 4 sales selling 14,244 shares for an estimated $8,636,599.
CHARLES EDWIN IV COLLINS (CHIEF EXECUTIVE OFFICER, GEMMA) has made 0 purchases and 2 sales selling 13,568 shares for an estimated $8,404,979.
PETER W GETSINGER has made 0 purchases and 4 sales selling 12,309 shares for an estimated $8,060,173.
JOHN RONALD JR. JEFFREY has made 0 purchases and 3 sales selling 11,334 shares for an estimated $5,835,232.
CYNTHIA FLANDERS sold 2,596 shares for an estimated $1,729,740
JOSHUA SCOTT BAUGHER (Chief Financial Officer) has made 0 purchases and 3 sales selling 1,360 shares for an estimated $920,667.
ALEXANDER LISA LARROQUE sold 350 shares for an estimated $220,703
KAREN SWEENEY sold 300 shares for an estimated $211,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AGX Hedge Fund Activity

We have seen 259 institutional investors add shares of $AGX stock to their portfolio, and 218 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 943,718 shares (+80.0%) to their portfolio in Q1 2026, for an estimated $500,510,278
LONE PINE CAPITAL LLC added 393,134 shares (+inf%) to their portfolio in Q1 2026, for an estimated $208,502,548
STATE STREET CORP added 205,653 shares (+65.9%) to their portfolio in Q1 2026, for an estimated $109,070,125
WCM INVESTMENT MANAGEMENT, LLC removed 203,157 shares (-89.8%) from their portfolio in Q1 2026, for an estimated $107,746,346
FIRST TRUST ADVISORS LP added 192,204 shares (+32.1%) to their portfolio in Q1 2026, for an estimated $101,937,313
UBS GROUP AG added 171,315 shares (+112.2%) to their portfolio in Q1 2026, for an estimated $90,858,623
VALUE ALIGNED RESEARCH ADVISORS, LLC removed 128,858 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,341,128

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AGX Congressional Stock Trading

Members of Congress have traded $AGX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AGX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $50,000 on 06/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$AGX Price Targets

Multiple analysts have issued price targets for $AGX recently. We have seen 4 analysts offer price targets for $AGX in the last 6 months, with a median target of $534.0.

Here are some recent targets:

Robert Brown from Lake Street set a target price of $600.0 on 06/05/2026
Michael Fairbanks from JP Morgan set a target price of $550.0 on 03/27/2026
Atidrip Modak from Goldman Sachs set a target price of $518.0 on 03/27/2026
An analyst from Freedom Capital Markets set a target price of $425.0 on 03/10/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.